“The apprehension with using non IID mentioned ingredients is justified as it's unachievable To judge if FDA would locate the ‘novel excipient’ Safe and sound for use in the drug product as there's no outlined process for analysis and approval of excipients. The FDA assistance on ‘Nonclinical Experiments for https://erwinr687dns7.bloggerswise.com/profile